Model-based Drug Development - Pharmacokinetic and Pharmacodynamic Modelling MSc

Our MSc Model-based Drug Development course provides the knowledge and skills in pharmacokinetics and pharmacodynamics for making evidence-based decisions at various stages of drug development. It is perfect for students who want to avoid lab work but stay in science.<br/><br/>You will develop your mathmatical modelling skills, there are no laboratory or animal-based components. Bioinformatics and molecular modelling are also not part of the course.<br/><br/>It covers the scientific and regulatory aspects of evaluating a drug, with emphasis on the use of mathematical modelling and simulation methods. You will learn why these methods are so highly valued by industry and regulatory authorities as effective, cost-saving, decision-making tools. Learning is reinforced via application of modelling and simulation skills to real pharmacokinetic and pharmacodynamic data.<br/><br/>The course has been developed with an emphasis on mechanistic approaches to assessing and predicting pharmacokinetics and pharmacodynamics (PKPD), such as physiologically-based pharmacokinetics (PBPK).<br/><br/>As this comes under the general umbrella of systems biology, you will be able to apply your knowledge of modelling and simulation in various areas of research within the pharmaceutical industry.<br/><br/>Full-time students benefit from immersion in the varied biomedical research environment at The University of Manchester, including interaction with research staff at the renowned Centre for Applied Pharmacokinetic Research.<br/><br/>Alternatively, part-time students already working in the pharmaceutical industry can take advantage of the flexible, distance learning mode of the course, which allows you to fit study around other commitments.